GRAIL, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
GRAL Nasdaq 2836 grail.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for GRAIL, Inc.

GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting - May 30th, 2026 6:00 am
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - May 27th, 2026 2:01 pm
GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - May 26th, 2026 2:01 pm
GRAIL to Present at the 2026 Jefferies Global Healthcare Conference - May 21st, 2026 2:01 pm
GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead - May 17th, 2026 10:02 am
How The GRAIL (GRAL) Narrative Is Shifting After NHS Galleri Results And Reimbursement Questions - May 8th, 2026 4:13 am
GRAIL Q1 Earnings Call Highlights - May 5th, 2026 6:38 pm
GRAIL Reports First Quarter 2026 Financial Results - May 5th, 2026 2:01 pm
GRAIL to Present at the BofA Securities 2026 Health Care Conference - Apr 30th, 2026 2:01 pm
Will Ultragenyx (RARE) Report Negative Q1 Earnings? What You Should Know - Apr 28th, 2026 8:00 am
GRAIL to Announce First Quarter 2026 Financial Results - Apr 22nd, 2026 2:01 pm
GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting - Apr 21st, 2026 2:53 pm
A Look At GRAIL (GRAL) Valuation After New Galleri Integrations With Epic Junction And Superpower - Apr 11th, 2026 6:12 am
GRAIL Partners With Epic to Broaden Galleri Test Access Across US - Apr 8th, 2026 9:24 am
GRAIL Announces Integration of the Galleri® Test into Epic Electronic Health Record Platform to Expand Access Nationwide - Apr 7th, 2026 2:01 pm
Cancer Is Striking Earlier -- Superpower and GRAIL Are Partnering to Expand Early Detection - Apr 1st, 2026 11:08 am
Grail (GRAL) Rated Buy by Guggenheim on Galleri Potential - Mar 31st, 2026 2:36 am
Block upgraded, Starbucks downgraded: Wall Street's top analyst calls - Mar 18th, 2026 7:34 am
Assessing GRAIL (GRAL) Valuation After Recent Share Price Pullback And Ongoing Growth Challenges - Mar 14th, 2026 6:08 am
GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor - Mar 12th, 2026 2:30 pm